Healthcare -
Biotechnology - NASDAQ - US
$ 35.06
-9.8 %
$ 3.29 B
Market Cap
-5.57
P/E
RARE - REVENUE
Revenue RARE - Ultragenyx Pharmaceutical Inc.
560 M
LAST VALUE
24.17%
2 YEAR CAGR
40.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR